DBV Technologies Information
Contact top employees from
DBV Technologies
Summary
DBV Technologies is a public company that has been in the industry for 24 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the CEO is occupied by Daniel Tasse. Its headquarters is located at Montrouge, Île-de-France, FR. The number of employees ranges from 100 to 250. The annual revenue of DBV Technologies varies between 5.0M and 25M. Total funding of the company - $120.8M. To connect with DBV Technologies employee register on SignalHire.
Organization Website | dbv-technologies.com |
Social Links |    |
Phone Number | 33-15-542-78-78, +33 (0)1 55 42 78 78 |
Industries | |
Headquarters Location | 107, Avenue de la République, Châtillon, France, 92320 FR |
Employees Size | 100-200 employees |
Specialties | Allergy, Food and pediatric allergy, Specific immunotherapy |
SIC Code | 2836 |
Founded | 2002 |
Estimated Annual Revenue | $5.0M - 25M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1987 | Public Company | 500 - 1.0K | 928.5M | $2.3B | |
| 2008 | Public Company | 500 - 1.0K | 157.5M | $226M | |
| 2005 | Privately Held | 25 - 100 | 3.5M | $96.7M | |
| 1998 | Public Company | 250 - 500 | 239.6M | $188.8M |
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at DBV Technologies shows a diverse range of experience levels:
3% have been with the company for less than 1 year8% for 1–2 years4% for 3–4 years37% for 5–7 years24% for 8–10 years25% have over 11 years of service at DBV TechnologiesEx-employees positions
In Company
In New Company
Contact top employees from
DBV Technologies
Angela Marcucci Mele
Vice President, Global Corporate Affairs and Communications
Christian Stollenmaier
Head of U.S. Purchasing
Andrew Finan
Vice President, Deputy General Counsel & Head of Compliance
Karen Disanto
Vice President, Human Resources (US & Australia)
Anne Pollak
Vice President, US Commercial Strategy
Katie Matthews
Head of Investor Relations | Associate Director of Research Strategy
Tee Bahnson
Vice President
Sree Menon
Vice President, Regulatory Affairs CMC
Matthew Solow
Vice President, Head of Intellectual Property
Todd Green
Vice President Clinical Development and Medical Affairs
Lora Araneo
Corporate Paralegal
Claudia Washington
Sr. Clinical Trial Associate
Callie Gautreaux
Senior Director, Quality
Michele Robertson
Chief Legal Officer
Helen Wang
Associate Medical Director, Clinical Development
Maribeth Kowalski
Senior Director, Medical & Scientific Communications and Information
Jessica Raviwong
VP, Global Quality
Joseph Chalil
Senior Medical Director, North America
Douglas Larson
Senior Director Finance
Lawrence Levey
Director Supply Chain
Hugo Le Roux
Senior Director, Global Regulatory Affairs
Joe Hammer
Combination Product Development Consultant
Kaivon Assani
Senior Manager, Human Factors & Usability
Jeff Sherman
Senior Director, Field Operations North America
Jodi Shroba CPNP
Associate Director, Clinical Development
Eileen Radovich
Office Manager/Administrative Assistant North America
Anne Cucinotta
Sr. CTA
James Briggs
Chief Human Resources Officer
Similar Companies
FAQ
DBV Technologies operates in the Biotech industries. More details can be found on the official website: dbv-technologies.com.
The headquarters of DBV Technologies are located in Châtillon, France.
The current CEO of DBV Technologies is Daniel Tasse
You can contact DBV Technologies by phone at 33-15-542-78-78, +33 (0)1 55 42 78 78.
DBV Technologies currently employs 100-200 people.
DBV Technologies's revenue is approximately 6M.
Well-known competitors of DBV Technologies include Novavax, Agios Pharmaceuticals, Immunomic Therapeutics, Inc. and Array BioPharma Inc..
